• Info
  • Insider Ownership

Insider Trading & Ownership of Gosebruch Henry O

Location
North Chicago, IL
Summary
The estimated net worth of Gosebruch Henry O is at least $22,346,022 dollars as of 23 May 2025. Gosebruch Henry O is the EVP, Chief Strategy Officer of AbbVie Inc. and owns shares of AbbVie Inc. (ABBV) stock worth about $15.28M. Gosebruch Henry O is the President & CEO, Director of Neumora Therapeutics, Inc. and owns shares of Neumora Therapeutics, Inc. (NMRA) stock worth about $7.07M.
Signature
/s/ Eddie Kim, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Gosebruch Henry O and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sponsored

Quick Takeaways

  • Gosebruch Henry O has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $22,346,022.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: AbbVie Inc. ($15,280,302).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Gosebruch Henry O

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ABBV AbbVie Inc. EVP, Chief Strategy Officer $15,280,302 16 May 2022
NMRA Neumora Therapeutics, Inc. President & CEO, Director $7,065,720 14 Feb 2024
SLRN ACELYRIN, Inc. Director $0 21 May 2025
APTX Aptinyx Inc. Director 26 May 2022

Insider Transactions Reported by Gosebruch Henry O:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.